Literature DB >> 22427625

Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions.

J Ollinger1, T O'Malley, J Ahn, J Odingo, T Parish.   

Abstract

Proteins secreted by bacteria perform functions vital for cell survival and play a role in virulence in Mycobacterium tuberculosis. M. tuberculosis lepB (Rv2903c) encodes the sole homolog of the type I signal peptidase (SPase). The lepB gene is essential in M. tuberculosis, since we could delete the chromosomal copy only when a second functional copy was provided elsewhere. By placing expression under the control of an anhydrotetracycline-inducible promoter, we confirmed that reduced lepB expression was detrimental to growth. Furthermore, we demonstrated that a serine-lysine catalytic dyad, characteristic for SPase function, is required for LepB function. We confirmed the involvement of LepB in the secretion of a reporter protein fused to an M. tuberculosis signal peptide. An inhibitor of LepB (MD3; a beta-aminoketone) was active against M. tuberculosis, exhibiting growth inhibition and bactericidal activity. Overexpression of lepB reduced the susceptibility of M. tuberculosis to MD3, and downregulation resulted in increased susceptibility, suggesting that LepB is the true target of MD3. MD3 lead to a rapid loss of viability and cell lysis. Interestingly, the compound had increased potency in nonreplicating cells, causing a reduction in viable cell numbers below the detection limit after 24 h. These data suggest that protein secretion is required to maintain viability under starvation conditions and that secreted proteins play a critical role in generating and surviving the persistent state. We conclude that LepB is a promising novel target for drug discovery in M. tuberculosis, since its inhibition results in rapid killing of persistent and replicating organisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427625      PMCID: PMC3347204          DOI: 10.1128/JB.00224-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

1.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement.

Authors:  T Parish; N G Stoker
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Analysis of a Streptococcus pneumoniae gene encoding signal peptidase I and overproduction of the enzyme.

Authors:  Y B Zhang; B Greenberg; S A Lacks
Journal:  Gene       Date:  1997-07-31       Impact factor: 3.688

3.  Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I.

Authors:  Palaniappan Kulanthaivel; Adam J Kreuzman; Mark A Strege; Matthew D Belvo; Tim A Smitka; Matthew Clemens; James R Swartling; Kristina L Minton; Feng Zheng; Eddie L Angleton; Deborah Mullen; Louis N Jungheim; Valentine J Klimkowski; Thalia I Nicas; Richard C Thompson; Sheng-Bin Peng
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

Review 4.  Global tuberculosis drug development pipeline: the need and the reality.

Authors:  Zhenkun Ma; Christian Lienhardt; Helen McIlleron; Andrew J Nunn; Xiexiu Wang
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

5.  Electroporation of mycobacteria.

Authors:  T Parish; N G Stoker
Journal:  Methods Mol Biol       Date:  1998

6.  Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis.

Authors:  Paul Carroll; D G Niranjala Muttucumaru; Tanya Parish
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

Review 7.  Type I signal peptidase: an overview.

Authors:  Renu Tuteja
Journal:  Arch Biochem Biophys       Date:  2005-09-15       Impact factor: 4.013

8.  Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor.

Authors:  Mark Paetzel; Jonathon J Goodall; Malgosia Kania; Ross E Dalbey; Malcolm G P Page
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

9.  Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.

Authors:  Vijaya Gracias; Zhiqin Ji; Irini Akritopoulou-Zanze; Cele Abad-Zapatero; Jeffrey R Huth; Danying Song; Philip J Hajduk; Eric F Johnson; Keith B Glaser; Patrick A Marcotte; Lori Pease; Nirupama B Soni; Kent D Stewart; Steven K Davidsen; Michael R Michaelides; Stevan W Djuric
Journal:  Bioorg Med Chem Lett       Date:  2008-03-10       Impact factor: 2.823

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  10 in total

Review 1.  The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.

Authors:  Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem Lett       Date:  2015-07-26       Impact factor: 2.823

2.  A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.

Authors:  Jee-Hyun Kim; Kathryn M O'Brien; Ritu Sharma; Helena I M Boshoff; German Rehren; Sumit Chakraborty; Joshua B Wallach; Mercedes Monteleone; Daniel J Wilson; Courtney C Aldrich; Clifton E Barry; Kyu Y Rhee; Sabine Ehrt; Dirk Schnappinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 3.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

4.  Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Authors:  Shawn I Walsh; Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem       Date:  2016-09-21       Impact factor: 3.641

5.  Regulated Expression Systems for Mycobacteria and Their Applications.

Authors:  Dirk Schnappinger; Sabine Ehrt
Journal:  Microbiol Spectr       Date:  2014

6.  Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening.

Authors:  Garth L Abrahams; Anuradha Kumar; Suzana Savvi; Alvin W Hung; Shijun Wen; Chris Abell; Clifton E Barry; David R Sherman; Helena I M Boshoff; Valerie Mizrahi
Journal:  Chem Biol       Date:  2012-07-27

7.  A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.

Authors:  Shilah A Bonnett; Juliane Ollinger; Susantha Chandrasekera; Stephanie Florio; Theresa O'Malley; Megan Files; Jo-Ann Jee; James Ahn; Allen Casey; Yulia Ovechkina; David Roberts; Aaron Korkegian; Tanya Parish
Journal:  ACS Infect Dis       Date:  2016-09-19       Impact factor: 5.084

8.  Novel T7 Phage Display Library Detects Classifiers for Active Mycobacterium Tuberculosis Infection.

Authors:  Harvinder Talwar; Samer Najeeb Hanoudi; Sorin Draghici; Lobelia Samavati
Journal:  Viruses       Date:  2018-07-19       Impact factor: 5.048

Review 9.  Countering Gram-Negative Antibiotic Resistance: Recent Progress in Disrupting the Outer Membrane with Novel Therapeutics.

Authors:  Kelly M Lehman; Marcin Grabowicz
Journal:  Antibiotics (Basel)       Date:  2019-09-24

Review 10.  The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis.

Authors:  Joanna C Evans; Valerie Mizrahi
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.